Effects of BW12C on Tumor Hypoxia and Blood Flow in Mice
Author Information
Author(s): D.J. Honess, D.E. Hu, N.M. Bleehen
Primary Institution: Medical Research Council Unit and University Department of Clinical Oncology and Radiotherapeutics
Hypothesis
Does BW12C increase tumor hypoxia and affect tissue perfusion in C3H mice?
Conclusion
BW12C significantly increases tumor hypoxia and reduces tumor perfusion in C3H mice.
Supporting Evidence
- BW12C increased the hypoxic fraction in RIF-1 and KHT tumors.
- Relative tissue perfusion was significantly reduced in tumors after BW12C treatment.
- Kidney, spleen, and lung showed increased perfusion after BW12C administration.
Takeaway
BW12C is a drug that makes tumors less oxygenated, which can help in cancer treatment by making other therapies work better.
Methodology
C3H mice were treated with BW12C and various assays were performed to measure tumor hypoxia and tissue perfusion.
Limitations
The study was limited to specific tumor types and sizes in mice, which may not fully represent human tumors.
Participant Demographics
Female C3H/Km mice, 10-16 weeks old.
Statistical Information
P-Value
p<0.001
Confidence Interval
(2.84-5.29)
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website